Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Holdings Lifted by Cetera Investment Advisers
Cetera Investment Advisers increased its holdings in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 35.8% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 4,459 shares of the biopharmaceutical company’s stock after purchasing an additional 1,175 shares during the quarter. Cetera Investment Advisers’ holdings in Intra-Cellular Therapies were worth $372,000 as […]
